Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

Presentation TCT 2024

TCT 1358: Fulminant Acute Hemolytic Anemia Due to Severe LVOT Obstruction After Transcatheter Mitral Valve Ring Implantation

Presenter: Huseyin Arman

October 30, 2024

Presentation TCT 2024

TCT 1515: Mechanical Hemolytic Anemia due to a Giant Paravalvular Mitral Leak: Is Percutaneous Closure Possible?

Presenter: Eloina Baltazar

October 29, 2024

Presentation NY Valves 2024

Resolution of Chronic Respiratory Failure and Transfusion-Dependent Anemia After Percutaneous Mitral Paravalvular Leak Closure Following Recent Surgical Mitral Valve Replacement

Presenter: Rahul Sawhney

June 05, 2024

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Todd Neale

March 15, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2023

Shelley Wood

November 30, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

News Conference News EuroPCR 2023

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

Caitlin E. Cox

May 19, 2023

News Daily News

Late Bleeding Not Rare, Ups Mortality After TAVI in All-Asian Cohort: OCEAN-TAVI

Yael L. Maxwell

September 08, 2022

News Opinion CV Team Dispatch

August 2022 News Roundup

L.A. McKeown

August 01, 2022

News Daily News

Short-term Mortality Higher in Transfused TAVR Patients

Todd Neale

December 10, 2020

Presentation TCT 2020

TCT 131: Outcomes in Transcatheter Aortic Valve Replacement in Patients With Anemia Requiring Red Blood Cell Transfusion; A Nationwide Prospective

Presenter: Ali Ghani

October 14, 2020

News Conference News CRT 2020

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

L.A. McKeown

February 27, 2020

News Daily News

TAVR Bleeds Stand Apart From PCI-Related Events

Caitlin E. Cox

August 06, 2019

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

News Daily News

Combining Frailty Index With Existing Risk Models Improves Mortality Prediction in TAVR

L.A. McKeown

February 22, 2018

News Conference News TCT 2017

Valve-in-Ring, Valve-in-MAC TMVR Procedures Feasible, but Patient Selection Is Key

Yael L. Maxwell

November 10, 2017

Presentation TCT 2017

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

News Daily News

Un Sistema Simple de Puntuación del Riesgo Predice la Mortalidad Post-TAVR

Michael O'Riordan

July 25, 2016

News Daily News

Simple Risk-Scoring System Predicts Mortality After TAVR

Michael O'Riordan

July 25, 2016

Advertisement

TCT 1358: Fulminant Acute Hemolytic Anemia Due to Severe LVOT Obstruction After Transcatheter Mitral Valve Ring Implantation

TCT 1515: Mechanical Hemolytic Anemia due to a Giant Paravalvular Mitral Leak: Is Percutaneous Closure Possible?

Resolution of Chronic Respiratory Failure and Transfusion-Dependent Anemia After Percutaneous Mitral Paravalvular Leak Closure Following Recent Surgical Mitral Valve Replacement

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

TCTMD’s Top 10 Most Popular Stories for November 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

Late Bleeding Not Rare, Ups Mortality After TAVI in All-Asian Cohort: OCEAN-TAVI

August 2022 News Roundup

Short-term Mortality Higher in Transfused TAVR Patients

TCT 131: Outcomes in Transcatheter Aortic Valve Replacement in Patients With Anemia Requiring Red Blood Cell Transfusion; A Nationwide Prospective

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

TAVR Bleeds Stand Apart From PCI-Related Events

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Combining Frailty Index With Existing Risk Models Improves Mortality Prediction in TAVR

Valve-in-Ring, Valve-in-MAC TMVR Procedures Feasible, but Patient Selection Is Key

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Un Sistema Simple de Puntuación del Riesgo Predice la Mortalidad Post-TAVR

Simple Risk-Scoring System Predicts Mortality After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content